Company Filing History:

5 out of 3,684

Bristol-myers Squibb Compnay

Years Active: 1993-2011

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7915395 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell (2011-03-29),

2. 6482919 - Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell (2002-11-19),

3. 6132992 - Expression vectors encoding bispecific fusion proteins and methods of (2000-10-17),

4. 5709859 - Mixed specificity fusion proteins (1998-01-20),

5. 5637481 - Expression vectors encoding bispecific fusion proteins and methods of (1997-06-10),

6. 5482856 - Production of chimeric antibodies by homologous recombination (1996-01-09),

7. 5204244 - Production of chimeric antibodies by homologous recombination (1993-04-20),

8. 5202238 - Production of chimeric antibodies by homologous recombination (1993-04-13),

Title: H Perry Fell - Innovator in Bispecific Fusion Proteins

Introduction

H Perry Fell, an accomplished inventor based in Redmond, WA, holds an impressive portfolio of 8 patents. His innovative work primarily revolves around the development of expression vectors capable of encoding bispecific fusion proteins, which have significant implications in the biomedical field.

Latest Patents

One of his notable patents is focused on the expression vectors encoding bispecific fusion proteins and methods for producing biologically active bispecific fusion proteins in mammalian cells. This invention details an expression vector that can encode either monospecific or bispecific fusion proteins. In one embodiment, it provides a vector that encodes a monospecific fusion protein comprising a DNA sequence for a first binding domain, which can bind to a specific cell surface antigen. The bispecific fusion protein version features two binding domains for different antigens, enhancing its versatility in therapeutic applications. Additionally, the patent outlines a method for effectively producing these biologically active fusion proteins within mammalian cells.

Career Highlights

Throughout his career, H Perry Fell has made remarkable contributions to the field of biotechnology. He has been associated with prominent companies, including Bristol-Myers Squibb Company and Oncogen, where his insights and inventions have catalyzed advancements in protein engineering and therapeutic solutions.

Collaborations

Fell has collaborated with various experts in the field, including Jeffrey A Ledbetter and Peter S Linsley. These partnerships have fostered a collaborative environment that has propelled the research and development of groundbreaking biomedical technologies.

Conclusion

H Perry Fell's work in the realm of bispecific fusion proteins is pivotal for the future of targeted therapies. With 8 patents to his name, his contributions to the biotechnology landscape exemplify the spirit of innovation and collaboration, promising significant advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.